Login

Ask AI

Companies $KLRA

$12.77 -$0.08 (0.62%) Close

$KLRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Kailera Therapeutics Inc

Financial Snapshot

Last updated: 10/27/2026

Size

Revenue: N/A
Net Income: N/A

Growth 2025

Revenue Growth: N/A
EPS Growth

Profitability

Gross Margin: N/A
Operating Margin: N/A
Net Income Margin: N/A

Cash flow

Free Cash Flow: N/A

Balance sheet 2026 Q2

Cash
Debt to Equity

Valuation Today

Market Cap: $1.66B
P/E: N/A

Company Facts

Industry: Pharmaceutical Preparations

Loading...

Comments